Hypoxia-selective targeting by the bioreductive prodrug AQ4N in patients with solid tumors: results of a phase 1 study
Loadman, Paul M.
Phillips, Roger M.
Twelves, Christopher J.
KeywordREF 2014; Hypoxia; Bioreductive prodrug; Topoisomerase II inhibitor; Pharmacodynamics; Tumor-targeting;